Due to COVID-19, a nationwide public health emergency was declared on Jan. 31. As such, The Drug Enforcement Administration (DEA) has relaxed rules previously in place with regards to prescribing controlled substances via telehealth. Per the DEA:
“For as long as the Secretary’s designation of a public health emergency remains in effect, DEA-registered practitioners may issue prescriptions for controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met:
- The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice.
- The telemedicine communication is conducted using an audio-visual, real-time, two-way interactive communication system.
- The practitioner is acting in accordance with applicable Federal and State law.”
The entire report can be read here.